ELITechGroup Molecular Diagnostics, Puteaux, France, has distributed more than 3.5 million SARS-CoV-2 tests worldwide. The company has also installed more than 500 of its lead diagnostics instrument, the ELITe InGenius polymerase chain reaction (PCR) system, globally, with over a hundred placed since the beginning of the pandemic. The system allows laboratories to reliably detect SARS-CoV-2, the virus that causes covid-19, in only a few hours, as well as conduct parallel testing for other diseases, such as flu, in order to ensure a correct diagnosis.

The ELITe InGenius is a fully automated solution that can process 12 samples in parallel to deliver results in less than 2.5 hours. This brings several benefits over centralized high-throughput testing approaches as there is no waiting for a large batch of samples to accumulate before testing, and no delays from sending samples off premises to a central laboratory. By performing extraction, amplification, and result interpretation in one device, the company says the ELITe InGenius replaces the multiple devices needed to perform such tasks separately.

Full automation also means there is no need for constant supervision, allowing laboratory staff to perform other valuable work. More importantly, the limited hands-on time helps reduce the risk of infection for users. The instrument is straightforward to use, with only minimal training from ELITechGroup’s service and support team required. The ELITe InGenius offers a wide molecular diagnostics menu on a sample-to-result system, with 38 CE-IVD assays dedicated to the individual needs of healthcare settings, be it immuno- compromised patient monitoring; detection of respiratory, gastro-intestinal, sexually transmitted or nosocomial infections; meningitis and encephalitis, or diagnostics of genetic factors.

“The continued rapid spread of the novel coronavirus makes it important for every country to test as many patients as possible, as quickly as possible,” says ELITechGroup CEO Christoph Gauer. “We are proud to have played an essential role in equipping healthcare staff with the testing tools they need. We have now expanded our manufacturing capacity to help provide additional ELITe InGenius systems to both new and existing hospitals and laboratories, globally and to support healthcare systems to prepare for the expectedly increasing demand for rapid and reliable diagnostics for all patients.”

For more information, visit ELITechGroup Molecular Diagnostics.